Titan Pharmaceuticals, Inc. (TTNP) Financials

$4.86

$0.25 (-4.8%)
Last update: 04:00 PM EST
Day's range
$4.86
Day's range
$5.1
$10M$10M$5M$5M$0$0-$5M-$5M-$10M-$10M-$15M-$15M-$20M-$20M-$25M-$25MEarning201820182019201920202020202120212022202220232023202420240%0%-100000%-100000%-200000%-200000%-300000%-300000%-400000%-400000%-500000%-500000%-600000%-600000%-700000%-700000%Profit Margin
Profit Margin
Revenue
Earnings

TTNP Income statement / Annual

Last year (2024), Titan Pharmaceuticals, Inc.'s total revenue was $0.00, a decrease of 100.00% from the previous year. In 2024, Titan Pharmaceuticals, Inc.'s net income was -$4.71 M. See Titan Pharmaceuticals, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Operating Revenue $0.00 $1.00 K $60.00 K $1.53 M $4.84 M $3.61 M $5.91 M $215.00 K $15.07 M $1.67 M
Cost of Revenue $5.00 K $0.00 $196.00 K $199.00 K $472.00 K $1.29 M $538.00 K $9.65 M $6.13 M $4.68 M
Gross Profit -$5.00 K $1.00 K -$136.00 K $1.33 M $4.37 M $2.32 M $5.37 M -$9.43 M $8.94 M -$3.00 M
Gross Profit Ratio 0 1 -2.27 0.87 0.9 0.64 0.91 -43.87 0.59 -1.8
Research and Development Expenses $0.00 $1.91 M $4.76 M $5.69 M $5.92 M $7.24 M $7.48 M $9.65 M $6.13 M $4.68 M
General & Administrative Expenses $4.56 M $5.55 M $6.03 M $4.99 M $5.80 M $5.40 M $0.00 $5.07 M $4.60 M $3.76 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $6.52 M $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $4.56 M $5.55 M $6.03 M $4.99 M $5.80 M $11.93 M $6.87 M $5.07 M $4.60 M $3.76 M
Other Expenses $0.00 -$183.00 K -$497.00 K -$84.00 K $0.00 $17.00 K -$6.00 K -$55.00 K $0.00 $0.00
Operating Expenses $4.56 M $7.28 M $10.30 M $10.68 M $11.72 M $19.17 M $13.64 M $14.72 M $10.72 M $8.43 M
Cost And Expenses $4.56 M $7.46 M $10.30 M $10.88 M $12.19 M $20.46 M $14.18 M $14.72 M $10.72 M $8.43 M
Interest Income $1.00 K $5.00 K $53.00 K $1.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $0.00 $0.00 $0.00 $0.00 $769.00 K $967.00 K $887.00 K $369.00 K $37.00 K $0.00
Depreciation & Amortization $5.00 K $112.00 K $196.00 K $221.00 K $292.00 K $244.00 K $380.00 K $417.00 K $377.00 K $358.00 K
EBITDA -$4.70 M -$7.17 M -$10.04 M -$9.13 M -$7.06 M -$6.28 M -$7.88 M -$14.09 M $4.72 M -$6.40 M
EBITDA Ratio 0 -7165 -167.32 -5.98 -1.46 -1.74 -1.33 -65.51 0.31 -3.83
Operating Income Ratio 0 -7277 -170.58 -6.13 -1.52 -4.66 -1.4 -67.45 0.29 -4.04
Total Other Income/Expenses Net -$149.00 K $1.71 M $29.00 K $578.00 K -$56.00 K $386.00 K -$759.00 K $195.00 K $792.00 K -$4.52 M
Income Before Tax -$4.71 M -$5.57 M -$10.21 M -$8.78 M -$7.41 M -$16.46 M -$9.02 M -$14.31 M $5.14 M -$11.28 M
Income Before Tax Ratio 0 -5569 -170.1 -5.75 -1.53 -4.56 -1.53 -66.54 0.34 -6.75
Income Tax Expense $0.00 $0.00 -$29.00 K -$662.00 K $13.32 M -$369.00 K $0.00 $0.00 $0.00 $0.00
Net Income -$4.71 M -$5.57 M -$10.18 M -$8.11 M -$20.73 M -$16.09 M -$9.02 M -$14.31 M $5.14 M -$11.28 M
Net Income Ratio 0 -5569 -169.62 -5.32 -4.28 -4.46 -1.53 -66.54 0.34 -6.75
EPS -5.23 -7.41 -15.15 -4.06 -10.38 -12602.35 -47.59 -121.48 44.71 -101.24
EPS Diluted -5.23 -7.41 -15.15 -4.06 -10.38 -9.83 -47.59 -121.34 36.01 -101.24
Weighted Average Shares Out $899.00 K $752.00 K $671.70 K $2.00 M $2.00 M $1.28 K $189.60 K $117.78 K $115.21 K $111.40 K
Weighted Average Shares Out Diluted $899.00 K $752.00 K $671.70 K $2.00 M $2.00 M $1.64 M $189.60 K $117.91 K $119.21 K $111.40 K
Link